To the Editor Dr Johnson and colleagues1 summarized the adverse events associated with immune checkpoint inhibitor therapy used to manage advanced cancers, which predominantly respond to treatment with glucocorticoids. However, we want to emphasize an irreversible adverse effect, autoimmune diabetes, which can present with life-threatening diabetic ketoacidosis and permanent insulin deficiency.
Akturk HK, Michels AW. Adverse Events Associated With Immune Checkpoint Inhibitors. JAMA. 2019;321(12):1219. doi:10.1001/jama.2018.22119
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: